A multidisciplinary team approach to hydroxyurea-associated chronic wound with squamous cell carcinoma

International Wound Journal

Volumn 9, Issue 3, 2012, Pages 324-329

  Stone, Tamar ^a   Berger, Alexandra ^a   Blumberg, Sheila ^a   O'Neill, Daniel ^a   Ross, Frank ^a   Mcmeeking, Alexander ^a   Chen, Weiliam ^a   Pastar, Irena ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hydroxyurea; Non healing wound; Polycythemia vera; Squamous cell carcinoma

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CLAVULANATE POTASSIUM; HYDROXYUREA; TRAMADOL;

ADULT; ANAMNESIS; ARTERIAL INSUFFICIENCY; ARTICLE; CANCER SURGERY; CASE REPORT; CHEMOSURGERY; DEBRIDEMENT; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOOT ULCER; HEEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PAIN; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SKIN GRAFT; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCAL SKIN INFECTION; TREATMENT OUTCOME; VENOUS REFLUX; WOUND HEALING;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHRONIC DISEASE; DEBRIDEMENT; FEMALE; HUMANS; HYDROXYUREA; LEG ULCER; MIDDLE AGED; MOHS SURGERY; POLYCYTHEMIA VERA; SKIN NEOPLASMS; SKIN TRANSPLANTATION; WOUND HEALING;

EID: 84860884313     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00887.x     Document Type: Article

References (33)

1. Krakoff IH, Brown NC, Reichard P. Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res 1968;28:1559-65.
2. Najean Y, Rain JD. Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 1997; 90:3370-7.
3. Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB. Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 2008;148:939-55.
4. Kumar B, Saraswat A, Kaur I. Rediscovering hydroxyurea: its role in recalcitrant psoriasis. Int J Dermatol 2001;40:530-4.
5. Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) [Research Support, Non-U.S. Gov't]. Lancet 2011; 377:1663-72.
6. Vassallo C, Passamonti F, Merante S, Ardigo M, Nolli G, Mangiacavalli S, Borroni G. Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia [Review]. Clin Exp Dermatol 2001;26:141-8.
7. Kalajian AH, Cely SJ, Malone JC, Burruss JB, Callen JP. Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiationexposure. Arch Dermatol 2010;146:305-10.
8. Oh ST, Lee DW, Lee JY, Cho BK. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption. J Am Acad Dermatol 2003;49:339-41.
9. Best PJ, Daoud MS, Pittelkow MR, Petitt RM. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 1998;128:29-32.
10. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975;111:183-7.
11. Nguyen TV, Margolis DJ. Hydroxyurea and lower leg ulcers. Cutis 1993;52:217-9.
12. Romanelli M, Dini V, Romanelli P. Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix. Arch Dermatol 2007;143: 1310-3.
13. Michiels JJ. Erythromelalgia and vascular complications in polycythemia vera. Semin Thromb Hemost 1997;23:441-54.
14. Michiels JJ, Berneman ZN, Schroyens W, Van Vliet HH. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera. Platelets 2004;15:67-84.
15. Michiels JJ. ten Kate FJ. Erythromelalgia in thrombocythemia of various myeloproliferative disorders. Am J Hematol 1992;39:131-6.
16. Haniffa MA, Speight EL. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes. Clin Exp Dermatol 2006;31:733-4.
17. Baldursson B, Sigurgeirsson B, Lindelof B. Venous leg ulcers and squamous cell carcinoma: a large-scale epidemiological study. Br J Dermatol 1995; 133:571-4.
18. Baldursson B, Sigurgeirsson B, Lindelof B. Leg ulcers and squamous cell carcinoma. An epidemiological study and a review of the literature. Acta Derm Venereol 1993;73:171-4.
19. Baldursson BT, Hedblad MA, Beitner H, Lindelof B. Squamous cell carcinoma complicating chronic venous leg ulceration: a study of the histopathology, course and survival in 25 patients. Br J Dermatol 1999;140:1148-52.
20. Kirsner RS, Spencer J, Falanga V, Garland LE, Kerdel FA. Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation. Dermatol Surg 1996;22:1015-8.
21. Goldberg DJ, Arbesfeld D. Squamous cell carcinoma arising in a site of chronic osteomyelitis. Treatment with Mohs micrographic surgery. J Dermatol Surg Oncol 1991;17:788-90.
22. Kirsner RS, Garland LD. Squamous cell carcinoma arising from chronic osteomyelitis treated by Mohs micrographic surgery. J Dermatol Surg Oncol 1994;20:141-3.
23. Baldursson B, Syrjanen S, Beitner H. Expression of p21WAF1/CIP1, p53, bcl-2 and Ki-67 in venous leg ulcers with and without squamous cell carcinoma. Acta Derm Venereol 2000;80:251-5.
24. Impola U, Jeskanen L, Ravanti L, Syrjanen S, Baldursson B, Kahari VM, Saarialho-Kere U. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 2005;152:720-6.
25. Sanchez-Palacios C, Guitart J. Hydroxyurea-associated squamous dysplasia. J Am Acad Dermatol 2004;51:293-300.
26. Ho CC, Siu WY, Lau A, Chan WM, Arooz T, Poon RY. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. Cancer Res 2006;66:2233-41.
27. Fitzpatrick JE, Hood AF. Histopathologic reactions to chemotherapeutic agents. Adv Dermatol 1988; 3:161-83.
28. Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005;167:59-69.
29. Pastar I, Stojadinovic O, Tomic-Canic M. Role of keratinocytes in healing of chronic wounds. Surg Technol Int 2008;17:105-12.
30. Soutou B, Aractingi S. Myeloproliferative disorder therapy: assessment and management of adverse events-a dermatologist's perspective. Hematol Oncol 2009;27 Suppl 1:11-3.
31. Flores F, Eaglstein WA, Kirsner RS. Hydroxyurea-induced leg ulcers treated with Apligraf. Ann Intern Med 2000;132:417-8.
32. Akinci B, Yesil S, Atabey A, Ilgezdi S. Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient. Exp Clin Endocrinol Diabetes 2007;115:143-5.
33. Kido M, Tago O, Fujiwara H, Ito M, Niwano H. Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline. Br J Dermatol 1998;139:1124-6.